Oaktree Acquisition Corp. III Life Sciences financial data

Symbol
OACC, OACCU, OACCW on Nasdaq
Location
333 South Grand Avenue, 28 Th Floor, Los Angeles, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147 %
Debt-to-equity -124 %

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -226K USD -369%
Nonoperating Income (Expense) 2.19M USD
Net Income (Loss) Attributable to Parent 1.97M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.33M USD
Assets, Current 1.48M USD
Assets 201M USD
Liabilities, Current 1.23M USD
Liabilities 8.25M USD
Retained Earnings (Accumulated Deficit) -6.77M USD
Stockholders' Equity Attributable to Parent -6.76M USD -29191%
Liabilities and Equity 201M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.6K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.33M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares